Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPoolbeg Pharma Regulatory News (POLB)

Share Price Information for Poolbeg Pharma (POLB)

Share Price is delayed by 15 minutes
Get Live Data
8.35    -0.15 (-1.76%)
Bid:
8.10
Ask:
8.60
Spread: 0.50 (6.173%)
Market Cap: £58.88m
POLB Live PriceLast checked at - London Stock Exchange

Intraday Poolbeg Pharma Share Chart

Form 8.5 (EPT/RI) - Poolbeg Pharma Plc

6 Feb 2025 10:36

Form 8.5 (EPT/RI) - Poolbeg Pharma Plc

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Name of exempt principal trader:Shore Capital Stockbrokers Ltd
(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereePoolbeg Pharma Plc
(c) Name of the party to the offer with which exempt principal trader is connected:Poolbeg Pharma Plc
(d) Date dealing undertaken:05 February 2025
(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?No

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

(a) Purchases and sales

Class of relevant securityPurchases/ sales Total number of securitiesHighest price per unit paid/receivedLowest price per unit paid/received
OrdinaryPurchases100,0005.121p5.121p
OrdinarySales6,2005.16p5.156p

(b) Derivatives transactions (other than option)

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
     

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
        

(ii) Exercising

Class of relevant securityProduct description e.g. call optionNumber of securitiesExercise price per unit
    

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
    

The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

Date of disclosure:06 February 2025
Contact name:Laura Parmenter
Telephone number:0207 647 8154

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
11th Feb 20258:42 amRNSForm 8.5 Poolbeg Pharma Plc
10th Feb 202510:59 amGNWForm 8.5 (EPT/RI) - Poolbeg Pharma Plc
10th Feb 20258:56 amRNSForm 8.5 Poolbeg Pharma Plc
7th Feb 202511:40 amGNWForm 8.5 (EPT/RI) - Poolbeg Pharma Plc
6th Feb 202510:36 amGNWForm 8.5 (EPT/RI) - Poolbeg Pharma Plc
5th Feb 202510:26 amGNWForm 8.5 (EPT/RI) - Poolbeg Pharma Plc
5th Feb 20259:20 amRNSForm 8.5 Poolbeg Pharma Plc
4th Feb 202511:40 amGNWForm 8.5 (EPT/RI) - Poolbeg Pharma Plc
3rd Feb 202511:28 amGNWForm 8.5 (EPT/RI) - Poolbeg Pharma Plc
3rd Feb 202510:59 amRNSForm 8.5 Poolbeg Pharma Plc
31st Jan 202511:46 amGNWForm 8.5 (EPT/RI) - Poolbeg Pharma Plc
31st Jan 20259:13 amRNSForm 8.5 - Poolbeg Pharma Plc
30th Jan 202510:34 amGNWForm 8.5 (EPT/RI) - Poolbeg Pharma Plc
30th Jan 20259:04 amRNSForm 8.5 Poolbeg Pharma Plc
30th Jan 20257:00 amRNSOffer Update - Extension to PUSU Deadline
29th Jan 202510:44 amGNWForm 8.5 (EPT/RI) - Poolbeg Pharma Plc
29th Jan 20259:16 amRNSForm 8.5 Poolbeg Pharma Plc
28th Jan 20259:47 amGNWForm 8.5 (EPT/RI) - Poolbeg Pharma Plc
28th Jan 20259:04 amRNSForm 8.5- Poolbeg Pharma PLC
27th Jan 202511:08 amGNWForm 8.5 (EPT/RI) - Poolbeg Pharma Plc
24th Jan 202511:48 amGNWForm 8.5 (EPT/RI) - Poolbeg Pharma Plc
24th Jan 202510:10 amRNSForm 8.5 (EPT/NON-RI)
23rd Jan 202511:31 amGNWForm 8.5 (EPT/RI) - Poolbeg Pharma Plc
23rd Jan 20259:55 amRNSForm 8.5 (EPT/NON-RI)
22nd Jan 202510:15 amGNWForm 8.5 (EPT/RI) - Poolbeg Pharma Plc
22nd Jan 20258:57 amRNSForm 8.5 (EPT/NON-RI)
21st Jan 202511:37 amGNWForm 8.5 (EPT/RI) - Poolbeg Pharma Plc
20th Jan 202511:49 amGNWForm 8.5 (EPT/RI) - Poolbeg Pharma Plc
20th Jan 202510:04 amRNSForm 8.5 (EPT/NON-RI)
17th Jan 20256:25 pmRNSReplacement - Form 8.3 - Poolbeg Pharma plc
17th Jan 202511:27 amRNSForm 8.3 - Poolbeg Pharma plc
17th Jan 202510:07 amRNSForm 8.5 Poolbeg Pharma PLC
16th Jan 20251:53 pmRNSForm 8.3 - Poolbeg Pharma plc
16th Jan 202510:58 amGNWForm 8.5 (EPT/RI) - Poolbeg Pharma Plc
16th Jan 20259:29 amRNSForm 8.5 (EPT/NON-RI)
15th Jan 20256:04 pmRNSForm 8.3 - Poolbeg Pharma plc
15th Jan 20252:57 pmRNSForm 8.3 - HOOKIPA PHARMA INC
15th Jan 20252:30 pmBUSForm 8.3 - HOOKIPA Pharma Inc.
15th Jan 202511:23 amGNWForm 8.5 (EPT/RI) - Poolbeg Pharma Plc
15th Jan 202510:31 amRNSForm 8.5 Poolbeg Pharma PLC
14th Jan 20255:33 pmRNSForm 8.3 - Poolbeg Pharma plc
14th Jan 20255:32 pmRNSForm 8.3 - Poolbeg Pharma plc
14th Jan 202511:06 amGNWForm 8.5 (EPT/RI) - Poolbeg Pharma Plc
13th Jan 20256:28 pmRNSForm 8.3 - Poolbeg Pharma plc
13th Jan 202510:41 amGNWForm 8.5 (EPT/RI) - Poolbeg Pharma Plc
13th Jan 202510:23 amRNSForm 8.5 (EPT/NON-RI)
10th Jan 202511:48 amRNSForm 8.5 (EPT/NON-RI)
10th Jan 202511:45 amGNWForm 8.5 (EPT/RI) - Poolbeg Pharma Plc
10th Jan 202510:47 amRNSForm 8.5 (EPT/NON-RI)
10th Jan 20257:00 amRNSUpdate Potential Combination of Poolbeg & HOOKIPA

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.